MedWatch

Saniona borrows USD 10m for clinical studies

The loan will be used to finance the clinical development of the biotech company's assets.

Rami Levin, President & Chief Executive Officer of Saniona | Photo: Saniona / PR

Biotech company Saniona has secured resources to continue the development of the company's assets as well as support general operations.

The listed company reports that it has taken out a non-dilutive term loan of USD 10m from asset manager Formue Nord.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs